Reuters26d
Akero soars as drug shows it reverses scarring in liver disease patients
Jan 27 (Reuters) - Akero Therapeutics (AKRO.O), opens new tab shares gained 117% in early trading on Monday, after its lead drug showed it can help patients with a type of liver disease to reverse ...
STAT26d
Akero drug reverses liver scarring in study of severe MASH patients
Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...
Frontiers10mon
The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma
Alpha-fetoprotein (AFP) is a glycoprotein synthesized by the liver and yolk sac during fetal development. However, the serum levels of AFP exhibit a significant correlation with the onset and ...
Frontiers2y
Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
Alpha-fetoprotein(AFP) is a cancer biomarker for the diagnosis ... 2.10 Phagocytosis assay with tumor-derived AFP (tAFP) A patient with liver cancer was recruited from the Department of Hepatobiliary ...